T. Rowe Price Associates’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-445,477	Closed	-$10.4M	–	2994
2021 Q2	$10.4M	Sell	445,477 -203,305	-31%	-$4.73M	﹤0.01%	1411
2021 Q1	$20.2M	Sell	648,782 -624	-0.1%	-$19.4K	﹤0.01%	1272
2020 Q4	$25.8M	Buy	+649,406	New	+$25.8M	﹤0.01%	1154